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Abstract
Despite over 50 years of research, a comprehensive understanding of how intramuscular triglyceride (IMTG) is stored in 
skeletal muscle and its contribution as a fuel during exercise is lacking. Immunohistochemical techniques provide informa-
tion on IMTG content and lipid droplet (LD) morphology on a fibre type and subcellular-specific basis, and the lipid dye Oil 
Red O (ORO) is commonly used to achieve this. BODIPY 493/503 (BODIPY) is an alternative lipid dye with lower back-
ground staining and narrower emission spectra. Here we provide the first quantitative comparison of BODIPY and ORO for 
investigating exercise-induced changes in IMTG content and LD morphology on a fibre type and subcellular-specific basis. 
Estimates of IMTG content were greater when using BODIPY, which was predominantly due to BODIPY detecting a larger 
number of LDs, compared to ORO. The subcellular distribution of intramuscular lipid was also dependent on the lipid dye 
used; ORO detects a greater proportion of IMTG in the periphery (5 μm below cell membrane) of the fibre, whereas IMTG 
content was higher in the central region using BODIPY. In response to 60 min moderate-intensity cycling exercise, IMTG 
content was reduced in both the peripheral (− 24%) and central region (− 29%) of type I fibres (P < 0.05) using BODIPY, 
whereas using ORO, IMTG content was only reduced in the peripheral region of type I fibres (− 31%; P < 0.05). As well 
as highlighting some methodological considerations herein, our investigation demonstrates that important differences exist 
between BODIPY and ORO for detecting and quantifying IMTG on a fibre type and subcellular-specific basis.
Keywords BODIPY · Oil Red O · Intramuscular triglyceride · Skeletal muscle
Introduction
Although lipid is predominantly stored in adipose tissue in 
humans, a small amount (~ 200 g) is also stored in skeletal 
muscle in the form of intramuscular triglyceride (IMTG). 
Healthy, trained individuals have large IMTG stores that are 
located in close proximity to, and even in contact with, mito-
chondria (Hoppeler 1999; Shaw et al. 2008), and IMTG is 
therefore an important fuel source during moderate-intensity 
exercise (van Loon 2004). However, obese type 2 diabetes 
patients also have large IMTG stores but are insulin resist-
ant (Goodpaster et al. 2001; Pan et al. 1997; van Loon et al. 
2004). The fact that athletes are able to combine high IMTG 
stores with superior insulin sensitivity has been termed the 
athletes paradox (Goodpaster et al. 2001). Moreover, it is 
because IMTG contributes minimally as a fuel source during 
exercise in sedentary, obese individuals and type 2 diabetes 
patients (van Loon 2004), that leads to IMTG accumulation 
and the development of insulin resistance (Chalkley et al. 
1998; Griffin et al. 1999; Itani et al. 2002; Yu et al. 2002). 
Given the continued rise in obesity and type 2 diabetes 
prevalence, there is a sustained effort to understand the link 
between lipid storage and metabolism in skeletal muscle and 
health and disease.
The first studies to investigate IMTG use during exercise 
employed biochemical triacylglycerol extraction analyses in 
mixed muscle samples obtained before and after exercise to 
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determine net changes in IMTG content. The findings from 
these studies, however, were equivocal with some reporting 
a decrease in IMTG following exercise (Essen-Gustavsson 
and Tesch 1990; Essen et al. 1977; Hurley et al. 1986; Watt 
et al. 2002), whereas others found no difference in IMTG 
content (Bergman et al. 1999; Kiens et al. 1993; Kiens and 
Richter 1998; Starling et al. 1997). The discrepant find-
ings can be attributed to a large between-biopsy variabil-
ity, driven by the presence of extramyocellular lipids which 
are located between the muscle fibres but which cannot 
be excluded from analysis of mixed muscle homogenates 
(van Loon 2004). Using immunofluorescence microscopy 
in conjunction with a lipid dye removes the confounding 
effect of extramyocellular lipids and permits IMTG content 
to be determined in a fibre type-specific manner (Koopman 
et al. 2001). Oil red O (ORO) is the most commonly used 
lipid dye to investigate lipid metabolism in skeletal muscle, 
and has been employed to demonstrate that IMTG content 
and use during exercise is greatest in type I fibres (Shep-
herd et al. 2013; van Loon et al. 2003). Importantly though, 
ORO does not exclusively stain IMTG, but labels all neutral 
lipids (e.g., phospholipids within membranes). Furthermore, 
ORO has a large emission spectrum (576–750 nm) which 
crosses the 543 nm, 594 nm and 633 nm excitation/emission 
channels (other commonly used colour channels in immu-
nofluorescence microscopy), making some co-staining com-
binations difficult and also resulting in a high background 
level of staining. The use of ORO to investigate lipid droplet 
(LD) morphology may also be inappropriate, since ORO is 
often dependent on the use of isopropanol, which has been 
reported to induce artificial fusion of LD in cultured mam-
malian cells (Listenberger and Brown 2007). An alternative 
neutral lipid stain is BODIPY 493/503 (BODIPY), which 
emits a bright green fluorescent signal. Methods for using 
BODIPY in combination with confocal immunofluores-
cence microscopy have been demonstrated in vitro (Listen-
berger et al. 2016), in rodent skeletal muscle (Prats et al. 
2006; Spangenburg et al. 2011) and human skeletal muscle 
(Jevons et al. 2020; Prats et al. 2013; Whytock et al. 2020). 
Importantly, BODIPY is more specific for detecting IMTG-
containing LD’s than Nile red in flow cytometry applica-
tions (Gocze and Freeman 1994), and when imaged using 
fluorescence emitted between 570 and 650 nm, it has been 
confirmed that most of the fluorescence is due to detection 
of IMTG (Prats et al. 2013). BODIPY may therefore provide 
the most accurate tool to identify LDs and quantify IMTG 
content in skeletal muscle, but a quantitative comparison 
between BODIPY and ORO is yet to be made.
With this in mind, the overarching aim of the current 
investigation was to compare BODIPY and ORO for quan-
tifying IMTG content and LD morphology in human skel-
etal muscle. First, we investigated fibre type and region 
(peripheral and central)-specific differences in IMTG 
content detected using BODIPY and ORO in muscle biop-
sies obtained after an overnight fast (study 1). In this con-
text, subcellular distribution is an important consideration 
because IMTG use during exercise occurs primarily in the 
central (intermyofibrillar) region of type I fibres of the cell 
(Jevons et al. 2020; Koh et al. 2017), and IMTG deposited in 
the peripheral (subsarcolemmal) region is inversely related 
to insulin sensitivity (Nielsen et al. 2017; Nielsen et al. 
2010). We also critically reviewed several steps in the immu-
nohistochemical protocol and analytical procedure that can 
affect the visualisation and quantification of IMTG content. 
Thus, using the optimised protocol and analytical procedure, 
we aimed to compare BODIPY and ORO for quantifying 
exercise-induced changes in IMTG content (study 2).
Methods
Subject characteristics—studies 1 and 2
The muscle samples used across this investigation were col-
lected as part of two previous studies from our laboratory 
(Shepherd et al. 2013, 2014). All participants were healthy, 
lean sedentary males, with selected subject characteristics 
for both studies presented in Table 1. All participants pro-
vided written informed consent, following a verbal explana-
tion of the nature and risks involved in the study (approved 
by the Black Country NHS Research Ethics Committee, 
West Midlands, UK).
Experimental procedures
For studies 1 and 2, maximal oxygen uptake  (VO2max) was 
initially determined during a progressive exercise test to 
exhaustion on an electronically braked cycle ergometer 
(Lode BV, Groningen, The Netherlands). At least 96 h later, 
subjects arrived at the laboratory following an overnight fast 
(> 10 h) and a muscle sample was obtained from the m. 
Table 1  Subject characteristics
Data presented are mean ± SD
BMI body mass index, Wmax maximum workload
Study 1 Study 2
n 6 8
Age (years) 20 ± 1 23 ± 3
Height (m) 1.69 ± 0.06 1.75 ± 0.06
Body Mass (kg) 70.3 ± 7.3 71.9 ± 6.5
BMI (kg.m−2) 24.8 ± 3.0 23.5 ± 1.9
VO2peak (L.min−1) 2.78 ± 0.38 2.96 ± 0.85
VO2peak (ml.min−1.kg−1) 39.8 ± 5.8 41.1 ± 11.6
Wmax (W) 183 ± 28 218 ± 35
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vastus lateralis of one leg under local anaesthesia (~ 5 ml 1% 
lidocaine) using the percutaneous needle biopsy technique 
with suction (Bergstrom et al. 1967). In study 2, participants 
then undertook 60 min of moderate-intensity exercise on 
an electronically braked cycle ergometer set at a workload 
equivalent to 65%  VO2max. A second muscle biopsy was 
taken immediately post-exercise from a separate incision 
made 2 cm proximal to the first on the same leg. All mus-
cle samples were blotted of excess blood and any visible 
fat and collagen was separated from the muscle tissue and 
discarded. The biopsy sample was then embedded in Tissue-
Tek OCT Compound (Sakura Finetek Europe, Zoeterwoude, 
The Netherlands) on a cork board which was immediately 
frozen in liquid nitrogen-cooled isopentane (Sigma-Aldrich, 
Dorset, UK) and stored in pre-cooled cryotubes at − 80 °C 
for histological analyses.
Immunofluorescence staining—Studies 1 and 2
Cryosections (5 µm) were cut using a microtome (Bright 
Instrument Company Limited, Huntingdon, England) housed 
within a cryostat at – 25 °C. The sections were collected onto 
uncoated, ethanol-cleaned glass slides (VWR International 
Ltd, Leicestershire, UK) and for study 2 sections from pre 
and post exercise biopsies were placed on the same slide 
to control for slide to slide variability. Samples were pre-
pared for histological analyses of IMTG in the same way for 
each lipid dye. The detailed methodology for both BODIPY 
and ORO can be found below. In preparation, cryosections 
were fixed for 1 h in 3.7% formaldehyde. Following 3 × 30 s 
rinses in doubly distilled water (dd  H2O), the slides were 
permeabilised in 0.5% Triton X-100 for 5 min. Subsequently, 
slides were washed 3 × 5 min in phosphate buffered saline 
(PBS, 137 mM sodium chloride, 3 mM potassium chloride, 
8 mM disodium hydrogen phosphate and 3 mM potassium 
dihydrogen phosphate, pH 7.4). Fibre type was determined 
using mouse anti-slow twitch myosin heavy chain antibody 
(MHCI; a4.840c developed by Dr Blau, DSHB, Iowa, USA) 
to label type I fibres and mouse anti-fast twitch IIA myosin 
heavy chain antibody (MHCIIa; 2F7, DSHB, Iowa, USA) to 
label type IIa fibres. Any fibres with no positive signal were 
then deemed to be type IIx fibres. Rabbit anti-laminin was 
used to identify the cell membrane (and used as a cell bor-
der for the purposes of analysis). The antibody solution was 
contained on the sections during the incubation through the 
use of a hydrophobic barrier pen (ImmEdge, Vector Labora-
tories, Burlingame, USA). Following 3 × 5 min wash in PBS, 
appropriate secondary antibodies were applied. The second-
ary antibodies were Alexa Fluor GAMIgG for anti-MHC 
IIa, Alexa Fluor GAMIgM for anti-MHCI and Alexa Fluor 
GARIgG for anti-laminin. Following a further 3 × 5 min 
wash in PBS the sections were incubated in either BODIPY 
or ORO (specific details of which are outlined below). At 
the end of the staining procedures coverslips were mounted 
onto the dried slides using Vectashield (H1000, Vectorlabs) 
and sealed using nail polish.
Oil Red O: A working solution of ORO was made for 
each staining procedure and consisted of 100 mg ORO 
(Sigma-Aldrich, UK) in 20  ml 60% triethylphosphate 
(Sigma-Aldrich, UK). Twelve ml of working solution was 
added to 8 ml dd  H2O and filtered twice using  Whatman® 
Grade 1 filter paper (11 µm particle retention) to remove any 
residual ORO crystals. The filtered ORO solution was then 
applied to the muscle sections for 30 min before a 10 min 
wash under cold, slowly running water.
BODIPY 493/503: A working solution of BODIPY 
(Difluoro{2-[1-(3,5-dimethyl-2H-pyrrol-2-ylidene-N)ethyl]-
3,5-dimethyl-1H-pyrrolato-N}boron) 493/503 was diluted 
from the stock solution as supplied (Sigma Aldrich, UK). 
The stock solution was diluted in PBS at a ratio of 1:50 
to create a working solution. BODIPY was applied to the 
muscle samples for 20 min before a 5 min wash in PBS. 
Due to the light sensitive nature of BODIPY, all work with 
BODIPY including the final washes and mounting of cov-
erslips was completed in a dark room.
Image capture, processing and data analysis
Images of cross-sectional orientated sections stained for 
ORO and BODIPY were captured using an inverted con-
focal microscope (Zeiss LSM710; Oberkochen, Germany) 
with a 63 × (1.4 NA) oil immersion objective. The pinhole 
was set at 1AU for all imaging to avoid pixel saturation. 
Images were captured at a 1.1 zoom allowing for one com-
plete cell to fill the field of view. ORO was excited with the 
HeNe 543 nm laser whilst BODIPY was excited using the 
488 nm argon laser. Alexa Fluor 633 was excited with the 
HeNe 633 nm laser and detected with 638–747 nm emission. 
Alexa Fluor 543 was excited with 543 nm laser and detected 
with 548–623 nm emission. Alexa Fluor 405 was excited 
using the 405 nm line of the diode laser and detected with 
371–422 nm emission. BODIPY emitted fluorescence was 
detected from 570–650 nm to specifically detect IMTG as 
suggested in Prats et al. (2013). The images were acquired 
at a resolution of 1024 × 1024 pixels and stored in 24‐bit 
tagged image format file format. Identical settings were used 
for all image capture for each fluorescent tag/dye within each 
participant.
As part of study 1, we aimed to investigate the variability 
and photostability of ORO and BODIPY staining. The coef-
ficient of variation (CV) of the BODIPY and ORO staining 
procedures was determined through the sequential imaging 
of serial cryosections on one slide. The same five type I 
fibres were identified on five serial cryosections and images 
were captured at a 1.1 × zoom allowing for ~ 1 cell to fill the 
field of view. The image capture settings were identical to 
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those listed above. To determine the photostability of the 
two dyes, the same five type I muscle fibres were imaged and 
total IMTG content was quantified from images captured 1, 
3, 6, 8, and 10 days following the initial staining. Slides were 
stored in the dark and at room temperature between imaging.
Confocal images were processed using Image-Pro Plus 5.1 
software (Media Cybernetics, MD, USA). To investigate the 
fibre type distribution of IMTG an intensity threshold was 
uniformly selected for both BODIPY and ORO to represent 
the positive IMTG signal. The corresponding laminin image 
was used to create a binary (black and white) image of the 
cell border and therefore the outline of the cell. A region-
specific (peripheral vs. central) analysis was performed; the 
cell border was then used to create a 5 µm ring inside the cell 
border, and was defined as the peripheral region of the cell. 
The remaining area was defined as the central region of the 
cell (Fig. 1). IMTG content was calculated for the whole cell 
and both the peripheral and central regions and in all cases 
expressed as the positively stained area fraction relative to 
the total area of interest (i.e., area of the cell defined as the 
peripheral or central region or the total cell). The number of 
LDs was expressed relative to the area of interest. Data on 
the area (size; µm2) of each individual spot (LD) were col-
lected per image, and used to calculate 1) the frequency of 
LDs over a range of sizes (100 nm groups), and 2) the mean 
area of individual LDs in an area of interest. For study 1, for 
each lipid dye analysis was completed for 20 type I fibres, 
16 (range 15–19) type IIa fibres and 9 (range 6–12) type IIx 
fibres were analysed per participant (total of 520 fibres across 
all participants; 262 for ORO and 258 for BODIPY). For 
ORO analysis this resulted in 5117 ± 681 LDs being analysed 
per participant (3237 ± 470 type I fibres, 1480 ± 216 type IIa 
Fig. 1  Region-specific image 
analysis. A grey scale image 
was created of both BODIPY 
staining (a) and the cell 
membrane (labelled using 
anti-laminin) (b). A 5 µm 
region was identified within 
the inside of the membrane (c). 
LD were then identified in this 
5 µm (peripheral) region (d) 
in addition to the remainder 
of the cell (central region) (e). 
The same procedure was used 
for region-specific analysis of 
images of ORO staining. White 
bar = 30 µm
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fibres and 365 ± 41 type IIx fibres). For BODIPY analysis, 
this resulted in a mean of 12695 ± 2138 LDs being analysed 
per participant (7799 ± 3267 type I fibres, 3936 ± 2164 type 
IIa fibres and 960 ± 433 type IIx fibres). For study 2, 13 
type I, 13 type IIa fibres and 8 (range 4–13) type IIx fibres 
were analysed per time-point (pre or post-exercise) per par-
ticipant (total of 808 fibres across all participants; 401 for 
ORO and 407 for BODIPY). For BODIPY, this resulted in 
a total of 19973 ± 3370 LDs being analysed per participant 
(12788 ± 7232 type I fibres, 6390 ± 3327 type IIa fibres and 
794 ± 433 type IIx fibres). For ORO, a total of 10433 ± 1759 
LDs were analysed per participant (6419 ± 3799 type I fibres, 
3571 ± 2269 type IIa fibres and 443 ± 253 type IIx fibres).
Statistics
All data are expressed as mean ± S.D. unless otherwise 
stated, and the significance threshold was set at P < 0.05. 
For study 1, a three-factor within-subjects repeated measures 
ANOVA was used to identify fibre type-specific differences 
in IMTG content, LD size and number between BODIPY 
and ORO staining based on the analysis of the whole cell, 
with the factors ‘fibre’ (type I vs. type IIa vs. type IIx fibres), 
‘stain’ (BODIPY vs ORO) and ‘region’ (peripheral vs. 
central). For study 2, exercise-induced changes in IMTG 
content, LD size and LD number using BODIPY and ORO 
were examined using a four-factor within-subjects repeated 
measures ANOVA with the additional factor ‘time’ (pre vs. 
post-exercise). Significant main effects or interactions were 
examined using Bonferroni adjustment post hoc analysis. In 
addition to the above analyses, a resampling without replace-
ment approach was used to explore the stability of estimates 
as the sample size (i.e., number of fibres sampled) changed. 
Further detail of this approach is provided in the results sec-
tion alongside a discussion of the findings.
Results
Study 1
BODIPY detects more IMTG than ORO
Irrespective of the lipid stain used, IMTG content (expressed 
as  % area stained) followed a hierarchical distribution across 
fibre types, such that IMTG content in type I fibres > type IIa 
fibres > type IIx fibres (main effect of fibre type; P < 0.01; 
see Fig. 2a). This fibre type distribution also remained true 
when IMTG content was determined in both the peripheral 
(5 µm band beneath the cell membrane) and central region 
of the cell (main effect of fibre type; P < 0.01; see Fig. 2a).
In all fibre types, IMTG content was greater when 
BODIPY was used to stain lipid compared to ORO (main 
effect of stain; P = 0.008). Overall, BODIPY detected 
more LDs than ORO (P = 0.03; Fig. 2b), and with a greater 
mean LD size than ORO (P = 0.03; Fig. 2c). We further 
Fig. 2  BODIPY detects more lipid than ORO. IMTG content (a), 
LD number (b) and LD size (c) in peripheral and central subcellular 
regions in type I, type IIa and type IIx fibres stained using BODIPY 
and ORO. IMTG content and LD number in each region was normal-
ized to total cell area. aDifferent from type I fibres (P < 0.01), bDif-
ferent from type IIa fibres (P < 0.01); cDifferent to ORO within fibre 
type (P < 0.05); dDifference between peripheral and central regions 
(P < 0.05). Values are mean ± S.D
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interrogated the difference in LD size between the two lipid 
stains by determining the frequency of LDs detected using 
BODIPY and ORO over a range of LD sizes (Fig. 3). Using 
this approach, it became apparent that ORO detects a greater 
number of small LDs (as a proportion of total LDs) compared 
to BODIPY in type I fibres (LDs up to 200 nm2; P < 0.01), 
type IIa fibres and type IIx fibres (LDs up to 100 nm2; 
P < 0.01). In contrast, BODIPY detected more LDs compared 
to ORO that were ≥ 400 nm2 in type I fibres (P < 0.01), 
and ≥ 300 nm2 in type IIa and type IIx fibres (P < 0.01).
Subcellular LD distribution differs by lipid dye
When separating the cell into peripheral (5 µm beneath 
the cell border) and central regions (remainder of the cell), 
the subcellular distribution of LDs differed depending on 
whether BODIPY or ORO was used as the lipid stain. In 
this regard, a significant stain × region interaction was 
detected (P = 0.001), and when this was interrogated the 
post hoc analysis revealed that IMTG content was greater 
in the central compared to the peripheral region across 
all fibre types when using BODIPY (P = 0.002; Fig. 2a). 
However, when using ORO, IMTG content did not dif-
fer between the peripheral compared to the central region 
in each of the fibre types examined (P = 0.11). Thus, 
when calculating the relative distribution of IMTG in 
each region and fibre type, differences between BODIPY 
and ORO were also apparent (Table 2). With BODIPY, 
IMTG content in the peripheral region contributed ~ 28% 
to total IMTG content across all fibres, which was signifi-
cantly less than the contribution of the peripheral region 
(~ 44%) to total IMTG content when analysed using ORO 
(P = 0.01; Table 2). Consequently, IMTG content in the 
central region contributed significantly more to total 
IMTG content when detected using BODIPY compared 
to ORO (P = 0.01; Table 2). Whilst the relative distri-
bution of IMTG in each region was uniform across all 
fibre types using BODIPY, this was not the case for ORO. 
Using ORO, the proportion of IMTG in the peripheral 
region compared to the central region was lower in type 
IIa fibres (P = 0.02) and tended to be lower in type I fibres 
(P = 0.07), but was not different between regions in type 
IIx fibres (P = 0.63; Table 2).
Finally, the regional differences in IMTG content for 
BODIPY and ORO were entirely attributed to differences 
in LD number (main effect for region, P = 0.039; Fig. 2b) but 
not LD size (no main effect of region, P = 0.492; Fig. 2c).
Fig. 3  Differences in LD frequency detected using BODIPY and 
ORO. We interrogated the difference in LD size and number between 
the two lipid stains by determining the frequency of LDs detected 
using BODIPY and ORO over a range of LD sizes in type I (a), type 
IIa (b) and type IIx (c) fibres. aGreater than corresponding BODIPY 
value (P < 0.05); bGreater than corresponding ORO value (P < 0.05). 
Values are mean ± S.D
Table 2  The relative distribution of IMTG at two subcellular loca-
tions in human skeletal muscle using Bodipy 493/503 and ORO
Values are geometric means and 95% CI
a P < 0.05 vs. central region within lipid dye
b P < 0.05 vs. corresponding region detected using ORO
Fibre type Bodipy 493/503 ORO
Peripheral Central Peripheral Central
Type I 27 (24–30)ab 73 (70–76)b 38 (24–52) 62 (48–76)
Type IIa 26 (25–27)ab 74 (73–75)b 43 (37–48)a 58 (52–63)
Type IIx 32 (28–37)ab 68 (63–72)b 52 (42–62) 48 (38–58)
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Reproducibility and photostability of BODIPY and ORO
Immunofluorescence analysis of IMTG content was per-
formed in five repeated slides to assess the reproducibil-
ity of the BODIPY and ORO. The reproducibility data are 
displayed in Table 3. The CV for IMTG content was 5.9% 
with BODIPY and 9.3% with ORO. For BODIPY, the vari-
ation in IMTG content could be explained by the variation 
in both LD number (CV = 3.9%) and LD size (CV = 2.9%). 
In contrast, the variation in IMTG content using ORO was 
largely due to variation in LD number (CV = 7.9%) rather 
than LD size (CV = 1.9%).
We also performed immunofluorescence analysis of 
BODIPY and ORO to investigate the photostability of the 
two lipid dyes. Images were obtained from the same five 
type I muscle fibres on one occasion (day 1) and then 3, 6, 8, 
10 and 13 days following the initial acquisition. After 3 days, 
IMTG content was similar whether using BODIPY or ORO 
(Fig. 4b). However, at day 6 there was a divergence, such 
that IMTG content investigated using ORO was reduced by 
19% (compared to day 1), whereas using BODIPY, IMTG 
content remained unchanged. After day 6, IMTG content 
decreased irrespective of whether BODIPY or ORO was 
used to stain lipid (Fig. 5). IMTG content decreased by 
32% using BODIPY by day 13, whereas IMTG content 
was decreased 63% by day 13 when using ORO (Fig. 4). 
It was interesting to note that using BODIPY, LD number 
was reduced 28% by day 3, and further reductions after 
this were relatively small (Fig. 4e). LD size was remained 
unchanged for BODIPY across the 13-day imaging period. 
When using ORO, LD number was unchanged at day 6, but 
then decreased dramatically by 51% by day 13. LD size was 
slightly reduced at day 3 (− 9%) and remained stable until 
day 8 using ORO, but was reduced 18% by 13.
Sample size considerations using BODIPY and ORO
Due to sampling variability, larger sample sizes produce 
more reliable results with greater precision and statistical 
power. Therefore, estimates of IMTG content determined 
using immunofluorescence microscopy will become more 
reliable as more fibres in a muscle section are sampled. In 
this study we aimed to sample 20 type I fibres and 15 type 
IIa fibres per subject to estimate IMTG content. Collecting 
this number of images is not only time-consuming when 
extrapolating to studies with multiple time points and larger 
sample sizes, but may not always be possible if tissue avail-
ability is limited. Therefore, we investigated how reducing 
the sample size (i.e., number of fibres analysed) would alter 
the mean IMTG content, compared to quantifying IMTG 
content from 20 type I or 15 type IIa fibres.
To achieve this, resampling was used to create new reali-
zations of the sampled fibres. This selected a random sample 
of n fibres (without replacement) from the full sample of 20 
type I fibres or 15 type IIa fibres. For each random sample, 
the mean IMTG content across the n fibres was calculated. 
The difference between this sample mean and the overall 
mean (of 20 or 15 type I or type II fibres, respectively) was 
determined, to obtain a single estimate of the difference in 
means. This process was then repeated 10,000 times, each 
time taking a random sample of n cells from the full sample 
and yielding an estimate of the difference in means. This 
was iteratively repeated for varying sample sizes (i.e., n = 1, 
2, …, 20). For each value of n, the mean differences from 
the 10,000 resamples were averaged, to produce a single 
estimate of the difference between the mean IMTG content 
for the n fibres compared to the mean IMTG content of the 
full 20 type I fibres (or 15 type IIa fibres). Due to the natu-
ral variation associated with an individual participant, the 
resampling process was applied to each individual’s samples 
separately.
Figure 5 illustrates how the sample mean deviates from 
the overall mean for varying sample sizes, expressed as a 
percentage difference. For the current data, if we sampled 
at least 13 cells, then the sample mean would be within 10% 
of the mean of 20 type I fibres and 15 type IIa fibres. This 
suggests that if we had sampled at least 13 cells, then we 
could reasonably rely on the sample not being too dissimilar 
(within 10%) to that of a larger size. Given that in most acute 
and chronic training interventions the changes expected 
in IMTG content will exceed 10% (Gemmink et al. 2016; 
Shepherd et al. 2012, 2013, 2017; van Loon et al. 2003), 
which also outweighs our reported coefficient of variation 
for BODIPY or ORO (above), we propose imaging of at 
least 13 fibres in order to generate a reliable estimate of 
IMTG content.
Study 2
Choice of lipid stain reveals differences in regional IMTG 
utilisation during exercise
Irrespective of the stain used, IMTG content was reduced in 
type I fibres only in response to 60 min moderate-intensity 
Table 3  Reproducibility of IMTG content measures with BODIPY 
and ORO
Measure Stain Mean (range) CV (%)
IMTG content (% 
area stained)
BODIPY 1.95 (1.85-2.12) 5.9
ORO 0.53 (0.48-0.59) 9.3
LD number
(LD µm−2)
BODIPY 0.096 (0.091-0.100) 3.9
ORO 0.039 (0.034-0.042) 7.9
LD size (µm2) BODIPY 0.232 (0.225-0.242) 2.9
ORO 0.172 (0.170-0.177) 1.7
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Fig. 4  Photo-stability of BODIPY and ORO. a Representative images 
of one type I muscle fibre stained with either BODIPY (green) or 
ORO (red) and imaged over a 13-day time-course using the same 
acquisition settings. The cell membrane (laminin) is depicted in pink. 
White bar = 30 µm. b IMTG content (mean of 5 fibres), LD number 
(d) and LD size (f) were calculated from the imaged fibres. The  % 
change from day 1 was subsequently calculated and plotted (c, e, and 
g for IMTG content, LD number, and LD size, respectively). Values 
are mean ± S.D
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exercise (fibre × time interaction; P = 0.048 (Figs. 6, 7a). No 
changes in IMTG content were observed following exercise in 
type IIa (P = 0.15) or IIx fibres (P = 0.63). Based on this ini-
tial observation, we next compared exercise-induced changes 
in IMTG content between stains on a region-specific basis 
within each fibre type (Fig. 7a). To this end, using BODIPY 
we observed a reduction in IMTG content in both the periph-
eral (P = 0.003) and central regions (P = 0.044) of type I fibres 
in response to 60 min moderate-intensity exercise. However, 
using ORO only a significant decrease in IMTG content in the 
peripheral region of type I fibres was observed (P = 0.007), 
with no change detected in the central region (P = 0.18; 
Fig. 7a). Moreover, irrespective of the stain used, the region-
specific reductions in IMTG content in type I fibres were 
attributed to a reduction in LD number (P = 0.003) (Fig. 7d), 
but not LD size (P = 0.028) (Fig. 7g).
Discussion
Immunofluorescence microscopy techniques used to visu-
alise and quantify IMTG content in human skeletal muscle 
have informed our current understanding of fibre type-
specific IMTG utilisation during exercise, as well as the 
relationship between IMTG content and insulin resistance. 
These observations are largely based on the results of stud-
ies that have used ORO to visualise and quantify IMTG 
content in human skeletal muscle. However, there are sev-
eral limitations to consider when using ORO. For example, 
ORO has a large emission spectrum (576-750 nm) which 
results in a high background level of staining, and con-
sequently it is often difficult to distinguish between the 
background staining and a positive lipid stain. Further-
more, ORO stains all neutral lipids, including membrane 
Fig. 5  Sample size considerations using BODIPY and ORO. Percent-
age change from the mean IMTG content obtained depending on the 
number of fibres analysed using BODIPY and ORO in type I (a, c) 
and type IIa fibres (b, d), respectively. Dashed lines represent individ-
ual participant data, whereas the bold continuous line is the average 
of all participants. Note that the analysis was performed using a max-
imum of 20 type I fibres and 15 type IIa fibres for each participant. 
Grey dashed lines represents 10% variation from the mean IMTG 
content calculated from 20 type I fibres or 15 type IIa fibres
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phospholipids (Prats et al. 2013) and cholesterol esters 
(Kruth and Fry 1984). Here, we aimed to directly compare 
ORO to another lipid dye, BODIPY, which is becoming 
increasingly popular as a means to detect and quantify 
IMTG content in human skeletal muscle.
The first novel finding was that using the lipid dye 
BODIPY resulted in a higher estimate of IMTG content 
compared to ORO in all fibre types of human skeletal 
muscle. Moreover, this was driven by BODIPY detecting 
a greater number of LDs that, on average, were larger in 
size. This may seem counter-intuitive, because one might 
assume that a higher background staining would actually 
increase the size of objects that are considered to be positive 
staining. However, by employing stringent positive detec-
tion limits for roundness and intensity, this can be avoided. 
Consequently, the probability of detecting smaller, non-spe-
cific objects may actually be increased when using ORO. In 
contrast, BODIPY can be imaged with minimal background 
staining present, making it much simpler to distinguish 
positive lipid staining. As a result, the number of LDs that 
can be detected using BODIPY is increased.
Our second novel observation is that the LD detection 
properties for BODIPY and ORO appear to diverge by 
subcellular region. That is, IMTG content detected using 
BODIPY was greater in the central region compared to 
the peripheral region (5 µm beneath membrane), whereas 
IMTG content detected using ORO was not different in the 
peripheral region compared to the central region. Given 
that ORO is not solely specific to IMTG it is possible that 
the greater proportion of IMTG detected by ORO staining 
in the peripheral region is due to the detection of mem-
brane lipids (Prats et al. 2013) such as cholesterol esters 
(Kruth and Fry 1984). This highlights why the specificity 
of the dye of choice is important. In contrast, BODIPY 
is considered to be more specific to IMTG, at least when 
imaged at 570 to 650 nm, with minimal staining of mem-
brane lipids (Prats et al. 2013). Therefore, the observation 
that IMTG content detected using BODIPY was greater in 
the central region compared to the peripheral region could 
Fig. 6  Fibre type specific lipid staining using BODIPY and ORO 
before and after exercise. For BODIPY panel of images, LDs stained 
before and after exercise using BODIPY (green) and cell membrane 
(pink) can be seen in the large images for type I (top), type IIa (mid-
dle) and type IIx (bottom). The smaller images show the corre-
sponding fibre type staining with MHCI denoting type I fibres (red) 
MHCIIa denoting type IIa fibres (blue) and no stain showing type IIx 
fibres. For ORO panel of images, LDs stained before and after exer-
cise using ORO (greyscale for clarity) and cell membrane (pink) can 
be seen in the large images for type I (top), type IIa (middle) and type 
IIx (bottom). The smaller images show the corresponding fibre type 
staining with MHCI denoting type I fibres (green) MHCIIa denot-
ing type IIa fibres (blue) and no stain showing type IIx fibres. White 
bar = 30 µm
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be considered to more accurately reflect subcellular differ-
ences in IMTG content. In this regard, studies employing 
transmission electron microscopy to investigate subcellu-
lar lipid content support this assertion, because they also 
demonstrate IMTG content to be greater in the central 
(or intermyofibrillar) region (Koh et al. 2017). Thus, it 
appears that the choice of lipid dye will have implications 
for the conclusions that are drawn from studies investigat-
ing regional differences in IMTG content and LD mor-
phology in human skeletal muscle in relation to health 
and disease.
As with any laboratory assay, the quality of the data it 
can generate is dependent on the variation of the assay, 
and we considered this for both ORO and BODIPY. We 
report that BODIPY has a CV of ~ 6% vs. ~ 9% for ORO 
(at least in our hands), demonstrating that labelling of LD 
with BODIPY is less variable than using ORO. We also 
show that BODIPY is more photo-stable compared to ORO, 
at least when measuring IMTG content. This is important 
from a methodological perspective as image capture may 
not occur immediately on completion of staining procedure. 
We imaged the same fibres over a period of 13 days during 
Fig. 7  Region-specific IMTG use during exercise labelling LDs 
with BODIPY and ORO. IMTG content (a–c), LD number (d–f) and 
LD size (g–i) in peripheral and central subcellular regions in type I, 
type IIa and type IIx fibres, respectively, stained using BODIPY and 
ORO. IMTG content and LD number in each region was normalized 
to total cell area. aDifferent from pre-exercise (P < 0.05), bDifference 
in peripheral region from pre to post-exercise (P < 0.05); cDifference 
in central region from pre to post-exercise (P < 0.05); dDifferent from 
type I fibres (P < 0.05); eDifferent from type IIa fibres (P < 0.05); 
fDifferent from corresponding BOD value (P < 0.05). Values are 
mean ± S.D
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which time the BODIPY staining was more photo-stable 
with 32% decrease in signal vs. 63% for ORO (Fig. 4). We 
do acknowledge that it would be both unusual and not rec-
ommended for stained slides to ever be imaged for the first 
time after 13 days. Nevertheless, the rate of the decline of 
the signals should perhaps be considered when using these 
immunofluorescence methods as both BODIPY and ORO 
showed a similar decrease in IMTG content after 3 days; 
however, at 6 days post-staining, there was decrease in lipid 
content detected of ~ 8% with BODIPY but ~ 19% with ORO 
and this decline continued to diverge until day 13. When 
considering LD morphology, we observed changes in both 
LD number and size that were dependent on the dye used 
3 days after staining (Fig. 4). Thus, divergence in LD mor-
phology (from day 1) occurred much sooner than significant 
changes in estimates of IMTG content, using either BODIPY 
or ORO. Taken together, this clearly has implications for 
the validity of the data generated and we suggest that the 
rate of signal decline, as well as the outcome of interest 
(i.e. content vs. morphology-related measures) is considered 
when conducting immunofluorescence microscopy experi-
ments, especially when signal intensity is a key quantifiable 
outcome measure.
The data in the current study were generated from 
the analysis of 20 type I and 20 type IIa cells, which 
included ~ 12,000 LDs per participant for BODIPY analy-
sis and ~ 5000 LDs per participant for ORO analysis. This 
is a much larger number of LDs analysed than has been 
reported in previous work using similar analytical methods 
and in a similar population (e.g., ~ 4000 LDs analysed by 
Gemmink et al. 2016). Thus, 20 type I fibres and 15 type 
IIa fibres could be considered exhaustive, as well as time-
consuming to image and analyse. Therefore, as part of the 
current investigation we aimed to determine an appropriate 
number of fibres to be imaged in future analyses. This was 
completed by comparing the variation from the mean (of 
20 or 15 type I or type IIa fibres, respectively) when cumu-
latively analysing more fibres (from 1 fibre up to 15 or 20 
fibres). Based on our relatively small sample of 6 individu-
als, this analysis revealed that 13 cells per fibre type results 
in an ~ 10% variation from the mean (of 20 fibres). Since 
we report a coefficient of variation for our assays of < 10% 
(for both BODIPY and ORO), and most acute and chronic 
exercise interventions will induce changes in IMTG content 
that exceed 10% (Gemmink et al. 2016; Shepherd et al. 2012, 
2013, Shepherd et al. 2017; van Loon et al. 2003), analysis 
of at least 13 fibres per fibre type (per time point) should pro-
vide the opportunity to detect a true and meaningful change 
in IMTG content. Whilst we do acknowledge that this num-
ber of fibres is unique to our data, future studies may use this 
as a point of reference, and should combine this information 
with their own CV for the assays that they use to determine 
changes in IMTG content.
Using the optimised protocol and analytical proce-
dure, we compared BODIPY and ORO for determining 
fibre type and subcellular-specific IMTG utilisation dur-
ing exercise. Irrespective of the lipid dye used, IMTG 
utilisation during exercise was specific to type I fibres, 
in line with a number of previous observations (Jevons 
et al. 2020; Shepherd et al. 2013; van Loon et al. 2003). 
However, the choice of lipid dye did reveal differences 
in IMTG utilisation during exercise when investigated 
on a subcellular-specific basis. While IMTG utilisation 
was of a similar magnitude in the central and peripheral 
regions when using BODIPY, utilisation of IMTG was 
specific to the peripheral region when examined using 
ORO. This latter finding is in direct contrast with a recent 
study employing transmission electron microscopy which 
reported that IMTG utilisation during high-intensity exer-
cise occurred exclusively in the intermyofibrillar region 
(Koh et  al. 2017). Whilst we acknowledge that using 
BODIPY may also not entirely replicate the observations 
made using high-resolution electron microscopy (because 
we observed exercise-induced decreases in IMTG content 
in both subcellular regions), our data suggest subcellular-
specific IMTG utilisation during exercise should not be 
investigated using ORO. Future work that uses BODIPY 
to detect IMTG should likely employ a smaller peripheral 
region (e.g., 2 µm as used in Jevons et al. 2020) since this 
may be more representative of the subsarcolemmal region 
detected using high-resolution electron microscopy.
In summary, our investigation has highlighted impor-
tant differences between BODIPY and ORO for detecting 
and quantifying IMTG on a fibre type and subcellular-
specific basis. We propose that BODIPY should be the dye 
of choice to investigate IMTG in skeletal muscle due to its 
lower CV, greater photo-stability and capability to specifi-
cally detect IMTG avoiding quantification of membrane 
structures, compared to ORO.
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